Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXWY0A
|
||||
| Drug Name |
N-(benzyloxycarbonyl)-phenylalanyl-glycine-nitrile
|
||||
| Synonyms |
CHEMBL344174
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C19H19N3O3
|
||||
| Canonical SMILES |
O=C(N[C@@H](Cc1ccccc1)C(=O)NCC#N)OCc2ccccc2
|
||||
| InChI |
InChI=1S/C19H19N3O3/c20-11-12-21-18(23)17(13-15-7-3-1-4-8-15)22-19(24)25-14-16-9-5-2-6-10-16/h1-10,17H,12-14H2,(H,21,23)(H,22,24)/t17-/m0/s1
|
||||
| InChIKey |
QXQAFIAKTXDYFI-KRWDZBQOSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.